Cargando…

Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy

The treatment of children with cerebral palsy with Botulinum toxin A injections is well established, safe and effective. However, a standardized injection strategy is still missing and the used dosage has escalated over the years. In the recent past, the recommended dosages in Europe were, however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Placzek, Richard, Siebold, Dagmar, Funk, Julia F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153296/
https://www.ncbi.nlm.nih.gov/pubmed/22069684
http://dx.doi.org/10.3390/toxins2092258
_version_ 1782209882465763328
author Placzek, Richard
Siebold, Dagmar
Funk, Julia F.
author_facet Placzek, Richard
Siebold, Dagmar
Funk, Julia F.
author_sort Placzek, Richard
collection PubMed
description The treatment of children with cerebral palsy with Botulinum toxin A injections is well established, safe and effective. However, a standardized injection strategy is still missing and the used dosage has escalated over the years. In the recent past, the recommended dosages in Europe were, however, reduced due to a better understanding of the relationship between dosage, severe side effects and the kind of anesthesia used. To combine safety and efficacy, the trend tends to a lower dosage, but combined with a more specific selection of injected muscles. The treatment of these key-muscles takes into account the best support for motor development to attain each individual motor milestone.
format Online
Article
Text
id pubmed-3153296
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-31532962011-11-08 Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy Placzek, Richard Siebold, Dagmar Funk, Julia F. Toxins (Basel) Review The treatment of children with cerebral palsy with Botulinum toxin A injections is well established, safe and effective. However, a standardized injection strategy is still missing and the used dosage has escalated over the years. In the recent past, the recommended dosages in Europe were, however, reduced due to a better understanding of the relationship between dosage, severe side effects and the kind of anesthesia used. To combine safety and efficacy, the trend tends to a lower dosage, but combined with a more specific selection of injected muscles. The treatment of these key-muscles takes into account the best support for motor development to attain each individual motor milestone. MDPI 2010-08-27 /pmc/articles/PMC3153296/ /pubmed/22069684 http://dx.doi.org/10.3390/toxins2092258 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Placzek, Richard
Siebold, Dagmar
Funk, Julia F.
Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
title Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
title_full Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
title_fullStr Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
title_full_unstemmed Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
title_short Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy
title_sort development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153296/
https://www.ncbi.nlm.nih.gov/pubmed/22069684
http://dx.doi.org/10.3390/toxins2092258
work_keys_str_mv AT placzekrichard developmentoftreatmentconceptsfortheuseofbotulinumtoxinainchildrenwithcerebralpalsy
AT siebolddagmar developmentoftreatmentconceptsfortheuseofbotulinumtoxinainchildrenwithcerebralpalsy
AT funkjuliaf developmentoftreatmentconceptsfortheuseofbotulinumtoxinainchildrenwithcerebralpalsy